Shingles Vaccine Market to hit USD 12.9 billion by 2034, says Global Market Insights Inc.
January 22, 2025 07:05 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Jan. 22, 2025 (GLOBE NEWSWIRE) -- Shingles vaccine market size was valued at USD 4.9 billion in 2024 and is projected to grow at a robust CAGR of 10.1% from 2025 to 2034. Key...
Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine
January 12, 2025 10:00 ET
|
Curevo Vaccine
Updated Phase 2 data one year after the second vaccine dose, the anti-gE antibody immune response to amezosvatein continues to be non-inferior to Shingrix
Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference
January 08, 2025 11:30 ET
|
Curevo Vaccine
Curevo Vaccine will present at the 2025 JPM Healthcare Conference on Wednesday January 15th.
Curevo Presents Positive Shingles Vaccine Outcomes Data
October 31, 2024 02:00 ET
|
Curevo Vaccine
Zero shingles cases after 18.8 months follow-up in 619 patients receiving any dose of amezosvatein, a development-stage adjuvanted subunit vaccine
Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week
October 16, 2024 11:00 ET
|
Curevo Vaccine
Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein elicits robust immune responses with better tolerability.
Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer
April 08, 2024 10:00 ET
|
Curevo Vaccine
SEATTLE, April 08, 2024 (GLOBE NEWSWIRE) -- Curevo Vaccine (Curevo), a privately-held clinical-stage biotechnology company dedicated to developing varicella zoster virus vaccines with improved...
Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix
January 07, 2024 11:00 ET
|
Curevo Vaccine
-- Positive data from 876-patient head-to-head trial versus Shingrix® shows amezosvatein met the primary immunogenicity endpoint, eliciting a robust immune response non-inferior to Shingrix, including...
Did CDC Suppress Data on Chickenpox Vaccine? Asks Article in Journal of American Physicians and Surgeons
March 29, 2022 10:09 ET
|
Association of American Physicians and Surgeons
TUCSON, Ariz., March 29, 2022 (GLOBE NEWSWIRE) -- The chickenpox (varicella) vaccine has markedly decreased the incidence of chickenpox. Although chickenpox is almost always a mild disease,...